| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
|
Lai, W. Victoria
|
|
2019
|
109 |
C |
p. 28-35
|
artikel
|
| 2 |
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial
|
Péron, Julien
|
|
2019
|
109 |
C |
p. 192-195
|
artikel
|
| 3 |
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma—a randomised multicentre trial (ASTER trial). An ANOCEF study
|
Ursu, R.
|
|
2019
|
109 |
C |
p. 129-136
|
artikel
|
| 4 |
A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes
|
Yonemori, Kan
|
|
2019
|
109 |
C |
p. 84-91
|
artikel
|
| 5 |
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
|
Wang, Zhen
|
|
2019
|
109 |
C |
p. 183-191
|
artikel
|
| 6 |
CMV disease and colitis in a kidney transplanted patient under pembrolizumab
|
Gueguen, Juliette
|
|
2019
|
109 |
C |
p. 172-174
|
artikel
|
| 7 |
Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer
|
Basak, Edwin A.
|
|
2019
|
109 |
C |
p. 12-20
|
artikel
|
| 8 |
Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
|
Johnson, Kaitlyn
|
|
2019
|
109 |
C |
p. 196-203
|
artikel
|
| 9 |
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity
|
Postel-Vinay, Sophie
|
|
2019
|
109 |
C |
p. 103-110
|
artikel
|
| 10 |
Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma
|
Robert, Caroline
|
|
2019
|
109 |
C |
p. 61-69
|
artikel
|
| 11 |
Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients
|
Rogado, J.
|
|
2019
|
109 |
C |
p. 21-27
|
artikel
|
| 12 |
Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial
|
Cremolini, Chiara
|
|
2019
|
109 |
C |
p. 175-182
|
artikel
|
| 13 |
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
|
Segal, Neil H.
|
|
2019
|
109 |
C |
p. 154-161
|
artikel
|
| 14 |
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1
|
Montemurro, Filippo
|
|
2019
|
109 |
C |
p. 92-102
|
artikel
|
| 15 |
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma
|
Shannan, B.
|
|
2019
|
109 |
C |
p. 137-153
|
artikel
|
| 16 |
Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study
|
Jørgensen, Siv Lykke
|
|
2019
|
109 |
C |
p. 1-11
|
artikel
|
| 17 |
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|
Smeland, Sigbjørn
|
|
2019
|
109 |
C |
p. 36-50
|
artikel
|
| 18 |
Symptom documentation and intervention provision for symptom control in children receiving cancer treatments
|
Hyslop, Shannon
|
|
2019
|
109 |
C |
p. 120-128
|
artikel
|
| 19 |
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
|
Pasquali, Sandro
|
|
2019
|
109 |
C |
p. 51-60
|
artikel
|
| 20 |
The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia
|
Frijstein, M.M.
|
|
2019
|
109 |
C |
p. 162-171
|
artikel
|
| 21 |
Treatment sequencing in metastatic colorectal cancer
|
Modest, D.P.
|
|
2019
|
109 |
C |
p. 70-83
|
artikel
|
| 22 |
Volume effect in paediatric brain tumour resection surgery: analysis of data from the Japanese national inpatient database
|
Shinjo, Daisuke
|
|
2019
|
109 |
C |
p. 111-119
|
artikel
|
Tijdschrift beschrijving